Article
Outcomes of chronic hepatitis C therapy in patients treated in community versus academic centres in Canada: final results of APPROACH (a prospective study of peginterferon alfa-2a and ribavirin at academic and community centres in Canada).
Canadian journal of gastroenterology = Journal canadien de gastroenterologie - 1 Sept 2011
Myers Robert P, Cooper Curtis, Sherman Morris, Lalonde Richard, Witt-Sullivan Helga, Elkashab Magdy, Harris Paul, Balshaw Robert, Usaty Chistopher, Marrotta Paul J
Abstract excerpt
BACKGROUND: In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic or community centres. METHODS: In the present observational study, adults with chronic HCV were treated with peginterferon alfa-2a 180 ìg⁄week plus ribavirin at 45 Canadian centres (16 academic, 29...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
